Tolerance Through Mixed Chimerism (Sip-Tego)

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Kidney Failure · Transplant Recipient (Kidney) · Transplant Tolerance · Immunosuppresion · Immunosuppression After Kidney Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Kerry Augusta, RN) · kaugusta@mgh.harvard.edu · 617-724-8570
Contact: Principal Investigator (Tatsuo Kawai, MD PhD)

Study leads

Tatsuo Kawai, MD PhD
Principal Investigator
Principal Investigator / Transplant Surgeon

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Concomitant Renal and Urinary Bladder Allograft Transplantation

Chronic Kidney Diseases · Bladder Dysfunction · Bladder Absence

Abroad (travel likely)RecruitingEARLY_PHASE1

Rochester, United States · Rochester, United States

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1

St Louis, United States